CN Patent

CN104168908A — 罗米地新制剂及其用途

Assigned to Celgene Corp · Expires 2014-11-26 · 11y expired

What this patent protects

本文提供罗米地新的制剂。还提供产生这些制剂的方法及其用途。在一个实施方案中，该制剂是罗米地新和甘露糖醇的组合。

USPTO Abstract

本文提供罗米地新的制剂。还提供产生这些制剂的方法及其用途。在一个实施方案中，该制剂是罗米地新和甘露糖醇的组合。

Drugs covered by this patent

quizartinib-dihydrochloride (QUIZARTINIB DIHYDROCHLORIDE)

Patent Metadata

Patent number: CN104168908A
Jurisdiction: CN
Classification: —
Expires: 2014-11-26
Drug substance claim: No
Drug product claim: No
Assignee: Celgene Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.